NCT00479154
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Restless Legs Syndrome
Explore clinical trials studying Restless Legs Syndrome. Study availability and eligibility vary by location and protocol.
148 public trials
9 recruiting studies
Restless Legs Syndrome trial results
Completed
Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
NCT00367822
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- IMEREM GmbH Nuremberg, Germany
NCT00626418
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- MD Clinical Hallandale, Florida, United States
- Sleep Disorders Center of Georgia Atlanta, Georgia, United States
- Community Research Crestview Hills, Kentucky, United States
- Clinilabs, Inc. New York, United States
NCT01125033
- Conditions
- Chronic Disease, Disease Attributes, Dyssomnias, +17 more
- Locations
-
- Shiraz University of Medical Sciences Shiraz, Fars, Iran
NCT00344994
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Medical College of Georgia Augusta, Georgia, United States
NCT00627003
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
Not specified
NCT00942253
- Conditions
- Behavior, Chronic Disease, Disease Attributes, +25 more
- Locations
-
- University Hospital of Larissa, Nephrology Clinic Larissa, Thessaly, Greece
NCT00557258
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Boehringer Ingelheim Investigational Site Aachen, Germany
- Boehringer Ingelheim Investigational Site Aalen, Germany
- Boehringer Ingelheim Investigational Site Ahlen, Germany
- Boehringer Ingelheim Investigational Site Altena, Germany
Completed
A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS
NCT00625547
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Pfizer Investigational Site Innsbruck, Austria
- Pfizer Investigational Site Vienna, Austria
- Pfizer Investigational Site Altötting, Germany
- Pfizer Investigational Site Aschaffenburg, Germany
NCT00479531
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- Christopher Lettieri MD Sleep Disorders Center, Walter Reed Army Medical Center, District of Columbia, United States